We are proud of the groundbreaking solutions we’ve been developing for COVID-19, glioblastoma, and other glioma tumors. Our development milestones illustrate the progress we’re making and our plans for the future.

• Two pending patents approaching the final submission phase
• Manufactured samples (in a pilot-scale lab) and conducted clinical trials for the           treatment of other diseases
• Laying of the cornerstone for a 4,200 sq meter production facility in Israel,                    on 14 May 2020